_id
69147c02ccc777a4e85d90d0
Ticker
MRVI
Name
Maravai Lifesciences Holdings Inc
Exchange
NASDAQ
Address
10770 Wateridge Circle, San Diego, CA, United States, 92121
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.maravai.com
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.
Last Close
3.67
Volume
1583955
Current Price
3.685
Change
0.40871934604904975
Last Updated
2025-12-02T12:08:07.368Z
Image
data:image/webp;base64,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
Ipo Date
2020-11-20T00:00:00.000Z
Market Cap
1238401280
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.3493
Sentiment Sources
3
Rating
3.8462
Target Price
3.8571
Strong Buy
5
Buy
1
Hold
7
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
41630000
Cost Of Revenue
35975000
Gross Profit
5655000
Operating Expenses
-109785000
Operating Income
115440000
Interest Expense
6844000
Pretax Income
-45149000
Net Income
-25556000
Eps
-0.1766344352826524
Dividends Per Share
-
Shares Outstanding
145022751
Income Tax Expense
-92000
EBITDA
-22463000
Operating Margin
277.3000240211386
Total Other Income Expense Net
-160589000
Cash
243574000
Short Term Investments
-
Receivables
22537000
Inventories
45326000
Total Current Assets
325867000
Property Plant Equipment
158624000
Total Assets
849191000
Payables
7998000
Short Term Debt
5440000
Long Term Debt
287381000
Total Liabilities
417332000
Equity
245443000
Depreciation
15842000
Change In Working Capital
6986000
Cash From Operations
-15150000
Capital Expenditures
2926000
Cash From Investing
-2926000
Cash From Financing
-8249000
Net Change In Cash
-26333000
PE
-
PB
2.1221171514363824
ROE
-10.412193462433233
ROA
-3.0094525259923857
FCF
-18076000
Fcf Percent
-0.4342061013692049
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
2
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
3
Net Net Investing Score
1
Quality Investing Score
3
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
41630000
Quarters > 0 > income Statement > cost Of Revenue
35975000
Quarters > 0 > income Statement > gross Profit
5655000
Quarters > 0 > income Statement > operating Expenses
-109785000
Quarters > 0 > income Statement > operating Income
115440000
Quarters > 0 > income Statement > interest Expense
6844000
Quarters > 0 > income Statement > pretax Income
-45149000
Quarters > 0 > income Statement > net Income
-25556000
Quarters > 0 > income Statement > eps
-0.1766344352826524
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
144683000
Quarters > 0 > income Statement > income Tax Expense
-92000
Quarters > 0 > income Statement > EBITDA
-22463000
Quarters > 0 > income Statement > operating Margin
277.3000240211386
Quarters > 0 > income Statement > total Other Income Expense Net
-160589000
Quarters > 0 > balance Sheet > cash
243574000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
22537000
Quarters > 0 > balance Sheet > inventories
45326000
Quarters > 0 > balance Sheet > total Current Assets
325867000
Quarters > 0 > balance Sheet > property Plant Equipment
158624000
Quarters > 0 > balance Sheet > total Assets
849191000
Quarters > 0 > balance Sheet > payables
7998000
Quarters > 0 > balance Sheet > short Term Debt
5440000
Quarters > 0 > balance Sheet > long Term Debt
287381000
Quarters > 0 > balance Sheet > total Liabilities
417332000
Quarters > 0 > balance Sheet > equity
245443000
Quarters > 0 > cash Flow > net Income
-25556000
Quarters > 0 > cash Flow > depreciation
15842000
Quarters > 0 > cash Flow > change In Working Capital
6986000
Quarters > 0 > cash Flow > cash From Operations
-15150000
Quarters > 0 > cash Flow > capital Expenditures
2926000
Quarters > 0 > cash Flow > cash From Investing
-2926000
Quarters > 0 > cash Flow > cash From Financing
-8249000
Quarters > 0 > cash Flow > net Change In Cash
-26333000
Quarters > 0 > ratios > PE
-0.1766344352826524
Quarters > 0 > ratios > PB
2.1221171514363824
Quarters > 0 > ratios > ROE
-10.412193462433233
Quarters > 0 > ratios > ROA
-3.0094525259923857
Quarters > 0 > ratios > FCF
-18076000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.4342061013692049
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
47397000
Quarters > 1 > income Statement > cost Of Revenue
39629000
Quarters > 1 > income Statement > gross Profit
7768000
Quarters > 1 > income Statement > operating Expenses
74046000
Quarters > 1 > income Statement > operating Income
-66278000
Quarters > 1 > income Statement > interest Expense
6815000
Quarters > 1 > income Statement > pretax Income
-74125000
Quarters > 1 > income Statement > net Income
-39591000
Quarters > 1 > income Statement > eps
-0.2744876452480657
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
144236000
Quarters > 1 > income Statement > income Tax Expense
-4288000
Quarters > 1 > income Statement > EBITDA
-51924000
Quarters > 1 > income Statement > operating Margin
-139.83585458995296
Quarters > 1 > income Statement > total Other Income Expense Net
-7847000
Quarters > 1 > balance Sheet > cash
269907000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
27882000
Quarters > 1 > balance Sheet > inventories
46667000
Quarters > 1 > balance Sheet > total Current Assets
359761000
Quarters > 1 > balance Sheet > property Plant Equipment
162727000
Quarters > 1 > balance Sheet > total Assets
896966000
Quarters > 1 > balance Sheet > payables
11525000
Quarters > 1 > balance Sheet > short Term Debt
6316000
Quarters > 1 > balance Sheet > long Term Debt
288436000
Quarters > 1 > balance Sheet > total Liabilities
428983000
Quarters > 1 > balance Sheet > equity
265859000
Quarters > 1 > cash Flow > net Income
-69837000
Quarters > 1 > cash Flow > depreciation
15386000
Quarters > 1 > cash Flow > change In Working Capital
1142000
Quarters > 1 > cash Flow > cash From Operations
-10265000
Quarters > 1 > cash Flow > capital Expenditures
2874000
Quarters > 1 > cash Flow > cash From Investing
-3236000
Quarters > 1 > cash Flow > cash From Financing
-1534000
Quarters > 1 > cash Flow > net Change In Cash
-15146000
Quarters > 1 > ratios > PE
-0.2744876452480657
Quarters > 1 > ratios > PB
1.953101456034966
Quarters > 1 > ratios > ROE
-14.891728322155728
Quarters > 1 > ratios > ROA
-4.413879678828406
Quarters > 1 > ratios > FCF
-13139000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.27721163786737557
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
46850000
Quarters > 2 > income Statement > cost Of Revenue
39125000
Quarters > 2 > income Statement > gross Profit
7725000
Quarters > 2 > income Statement > operating Expenses
56887000
Quarters > 2 > income Statement > operating Income
-49162000
Quarters > 2 > income Statement > interest Expense
6778000
Quarters > 2 > income Statement > pretax Income
-52691000
Quarters > 2 > income Statement > net Income
-29945000
Quarters > 2 > income Statement > eps
-0.20878507930974377
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
143425000
Quarters > 2 > income Statement > income Tax Expense
162000
Quarters > 2 > income Statement > EBITDA
-31003000
Quarters > 2 > income Statement > operating Margin
-104.93489861259337
Quarters > 2 > income Statement > total Other Income Expense Net
-3529000
Quarters > 2 > balance Sheet > cash
285053000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
28493000
Quarters > 2 > balance Sheet > inventories
49773000
Quarters > 2 > balance Sheet > total Current Assets
376282000
Quarters > 2 > balance Sheet > property Plant Equipment
166428000
Quarters > 2 > balance Sheet > total Assets
959751000
Quarters > 2 > balance Sheet > payables
9525000
Quarters > 2 > balance Sheet > short Term Debt
6274000
Quarters > 2 > balance Sheet > long Term Debt
289499000
Quarters > 2 > balance Sheet > total Liabilities
429478000
Quarters > 2 > balance Sheet > equity
300614000
Quarters > 2 > cash Flow > net Income
-29945000
Quarters > 2 > cash Flow > depreciation
14910000
Quarters > 2 > cash Flow > change In Working Capital
5490000
Quarters > 2 > cash Flow > cash From Operations
-9390000
Quarters > 2 > cash Flow > capital Expenditures
5235000
Quarters > 2 > cash Flow > cash From Investing
-23129000
Quarters > 2 > cash Flow > cash From Financing
-4900000
Quarters > 2 > cash Flow > net Change In Cash
-37346000
Quarters > 2 > ratios > PE
-0.20878507930974377
Quarters > 2 > ratios > PB
1.7175846766950307
Quarters > 2 > ratios > ROE
-9.961279248471461
Quarters > 2 > ratios > ROA
-3.120080104110337
Quarters > 2 > ratios > FCF
-14625000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.3121664887940235
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
56406000
Quarters > 3 > income Statement > cost Of Revenue
37444000
Quarters > 3 > income Statement > gross Profit
18962000
Quarters > 3 > income Statement > operating Expenses
57092000
Quarters > 3 > income Statement > operating Income
-38130000
Quarters > 3 > income Statement > interest Expense
11263000
Quarters > 3 > income Statement > pretax Income
-46502000
Quarters > 3 > income Statement > net Income
-26145000
Quarters > 3 > income Statement > eps
-0.18711018711018712
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
139730500
Quarters > 3 > income Statement > income Tax Expense
-7000
Quarters > 3 > income Statement > EBITDA
-20713000
Quarters > 3 > income Statement > operating Margin
-67.59919157536433
Quarters > 3 > income Statement > total Other Income Expense Net
-8372000
Quarters > 3 > balance Sheet > cash
322399000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
38520000
Quarters > 3 > balance Sheet > inventories
50082000
Quarters > 3 > balance Sheet > total Current Assets
429146000
Quarters > 3 > balance Sheet > property Plant Equipment
217025000
Quarters > 3 > balance Sheet > total Assets
1008244000
Quarters > 3 > balance Sheet > payables
11957000
Quarters > 3 > balance Sheet > short Term Debt
13713000
Quarters > 3 > balance Sheet > long Term Debt
290492000
Quarters > 3 > balance Sheet > total Liabilities
431035000
Quarters > 3 > balance Sheet > equity
325292000
Quarters > 3 > cash Flow > net Income
-26145000
Quarters > 3 > cash Flow > depreciation
15184000
Quarters > 3 > cash Flow > change In Working Capital
-12808000
Quarters > 3 > cash Flow > cash From Operations
-14638000
Quarters > 3 > cash Flow > capital Expenditures
5849000
Quarters > 3 > cash Flow > cash From Investing
-4931000
Quarters > 3 > cash Flow > cash From Financing
-236189000
Quarters > 3 > cash Flow > net Change In Cash
-255758000
Quarters > 3 > ratios > PE
-0.18711018711018712
Quarters > 3 > ratios > PB
1.5463946239071358
Quarters > 3 > ratios > ROE
-8.037394095151432
Quarters > 3 > ratios > ROA
-2.5931222997607724
Quarters > 3 > ratios > FCF
-20487000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.36320604191043504
Quarters > 3 > health Score
25
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
259185000
Annuals > 0 > income Statement > cost Of Revenue
150876000
Annuals > 0 > income Statement > gross Profit
108309000
Annuals > 0 > income Statement > operating Expenses
343926000
Annuals > 0 > income Statement > operating Income
-235617000
Annuals > 0 > income Statement > interest Expense
47700000
Annuals > 0 > income Statement > pretax Income
-261482000
Annuals > 0 > income Statement > net Income
-144846000
Annuals > 0 > income Statement > eps
-1.0503241338302902
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
137906000
Annuals > 0 > income Statement > income Tax Expense
-1860000
Annuals > 0 > income Statement > EBITDA
-156917000
Annuals > 0 > income Statement > operating Margin
-90.90688118525378
Annuals > 0 > income Statement > total Other Income Expense Net
-25865000
Annuals > 0 > balance Sheet > cash
322399000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
38520000
Annuals > 0 > balance Sheet > inventories
50082000
Annuals > 0 > balance Sheet > total Current Assets
429146000
Annuals > 0 > balance Sheet > property Plant Equipment
217025000
Annuals > 0 > balance Sheet > total Assets
1008244000
Annuals > 0 > balance Sheet > payables
11957000
Annuals > 0 > balance Sheet > short Term Debt
13713000
Annuals > 0 > balance Sheet > long Term Debt
290492000
Annuals > 0 > balance Sheet > total Liabilities
431035000
Annuals > 0 > balance Sheet > equity
325292000
Annuals > 0 > cash Flow > net Income
-259622000
Annuals > 0 > cash Flow > depreciation
56865000
Annuals > 0 > cash Flow > change In Working Capital
-12614000
Annuals > 0 > cash Flow > cash From Operations
7465000
Annuals > 0 > cash Flow > capital Expenditures
29658000
Annuals > 0 > cash Flow > cash From Investing
-24316000
Annuals > 0 > cash Flow > cash From Financing
-235712000
Annuals > 0 > cash Flow > net Change In Cash
-252563000
Annuals > 0 > ratios > PE
-1.0503241338302902
Annuals > 0 > ratios > PB
1.432934963048584
Annuals > 0 > ratios > ROE
-44.52799331062553
Annuals > 0 > ratios > ROA
-14.36616533299479
Annuals > 0 > ratios > FCF
-22193000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.08562609718926635
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
288945000
Annuals > 1 > income Statement > cost Of Revenue
148743000
Annuals > 1 > income Statement > gross Profit
140202000
Annuals > 1 > income Statement > operating Expenses
171850000
Annuals > 1 > income Statement > operating Income
-31648000
Annuals > 1 > income Statement > interest Expense
45892000
Annuals > 1 > income Statement > pretax Income
617736000
Annuals > 1 > income Statement > net Income
-119029000
Annuals > 1 > income Statement > eps
-0.9022885255346084
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
131919000
Annuals > 1 > income Statement > income Tax Expense
756111000
Annuals > 1 > income Statement > EBITDA
712409000
Annuals > 1 > income Statement > operating Margin
-10.952949523265673
Annuals > 1 > income Statement > total Other Income Expense Net
649384000
Annuals > 1 > balance Sheet > cash
574962000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
55723000
Annuals > 1 > balance Sheet > inventories
51397000
Annuals > 1 > balance Sheet > total Current Assets
699912000
Annuals > 1 > balance Sheet > property Plant Equipment
222646000
Annuals > 1 > balance Sheet > total Assets
1487450000
Annuals > 1 > balance Sheet > payables
10729000
Annuals > 1 > balance Sheet > short Term Debt
12853000
Annuals > 1 > balance Sheet > long Term Debt
518707000
Annuals > 1 > balance Sheet > total Liabilities
697566000
Annuals > 1 > balance Sheet > equity
416753000
Annuals > 1 > cash Flow > net Income
-119029000
Annuals > 1 > cash Flow > depreciation
48781000
Annuals > 1 > cash Flow > change In Working Capital
97844000
Annuals > 1 > cash Flow > cash From Operations
126224000
Annuals > 1 > cash Flow > capital Expenditures
65553000
Annuals > 1 > cash Flow > cash From Investing
-122310000
Annuals > 1 > cash Flow > cash From Financing
-61090000
Annuals > 1 > cash Flow > net Change In Cash
-57176000
Annuals > 1 > ratios > PE
-0.9022885255346084
Annuals > 1 > ratios > PB
1.069905243633519
Annuals > 1 > ratios > ROE
-28.56104215206609
Annuals > 1 > ratios > ROA
-8.002218561968471
Annuals > 1 > ratios > FCF
60671000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.20997421654640155
Annuals > 1 > health Score
44
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
883001000
Annuals > 2 > income Statement > cost Of Revenue
168957000
Annuals > 2 > income Statement > gross Profit
714044000
Annuals > 2 > income Statement > operating Expenses
139828000
Annuals > 2 > income Statement > operating Income
574216000
Annuals > 2 > income Statement > interest Expense
20414000
Annuals > 2 > income Statement > pretax Income
551472000
Annuals > 2 > income Statement > net Income
220205000
Annuals > 2 > income Statement > eps
1.672083222597669
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
131695000
Annuals > 2 > income Statement > income Tax Expense
60809000
Annuals > 2 > income Statement > EBITDA
609989000
Annuals > 2 > income Statement > operating Margin
65.03005092859465
Annuals > 2 > income Statement > total Other Income Expense Net
-22744000
Annuals > 2 > balance Sheet > cash
632138000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
146814000
Annuals > 2 > balance Sheet > inventories
43152000
Annuals > 2 > balance Sheet > total Current Assets
847902000
Annuals > 2 > balance Sheet > property Plant Equipment
116590000
Annuals > 2 > balance Sheet > total Assets
2282315000
Annuals > 2 > balance Sheet > payables
5991000
Annuals > 2 > balance Sheet > short Term Debt
11709000
Annuals > 2 > balance Sheet > long Term Debt
521997000
Annuals > 2 > balance Sheet > total Liabilities
1377072000
Annuals > 2 > balance Sheet > equity
545218000
Annuals > 2 > cash Flow > net Income
490663000
Annuals > 2 > cash Flow > depreciation
38103000
Annuals > 2 > cash Flow > change In Working Capital
-45082000
Annuals > 2 > cash Flow > cash From Operations
535977000
Annuals > 2 > cash Flow > capital Expenditures
17090000
Annuals > 2 > cash Flow > cash From Investing
-267612000
Annuals > 2 > cash Flow > cash From Financing
-187499000
Annuals > 2 > cash Flow > net Change In Cash
80866000
Annuals > 2 > ratios > PE
1.672083222597669
Annuals > 2 > ratios > PB
0.8164240725728057
Annuals > 2 > ratios > ROE
40.38843178325
Annuals > 2 > ratios > ROA
9.648317607341667
Annuals > 2 > ratios > FCF
518887000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.5876403310981527
Annuals > 2 > health Score
79
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
799240000
Annuals > 3 > income Statement > cost Of Revenue
140561000
Annuals > 3 > income Statement > gross Profit
658679000
Annuals > 3 > income Statement > operating Expenses
104034000
Annuals > 3 > income Statement > operating Income
554645000
Annuals > 3 > income Statement > interest Expense
30260000
Annuals > 3 > income Statement > pretax Income
530765000
Annuals > 3 > income Statement > net Income
182037000
Annuals > 3 > income Statement > eps
1.4925286248980245
Annuals > 3 > income Statement > dividends Per Share
153451000
Annuals > 3 > income Statement > shares Outstanding
121965500
Annuals > 3 > income Statement > income Tax Expense
61515000
Annuals > 3 > income Statement > EBITDA
585777000
Annuals > 3 > income Statement > operating Margin
69.39655172413794
Annuals > 3 > income Statement > total Other Income Expense Net
-23880000
Annuals > 3 > balance Sheet > cash
551272000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
117512000
Annuals > 3 > balance Sheet > inventories
51557000
Annuals > 3 > balance Sheet > total Current Assets
740039000
Annuals > 3 > balance Sheet > property Plant Equipment
95427000
Annuals > 3 > balance Sheet > total Assets
1918276000
Annuals > 3 > balance Sheet > payables
8154000
Annuals > 3 > balance Sheet > short Term Debt
9722000
Annuals > 3 > balance Sheet > long Term Debt
524591000
Annuals > 3 > balance Sheet > total Liabilities
1372915000
Annuals > 3 > balance Sheet > equity
315499000
Annuals > 3 > cash Flow > net Income
469250000
Annuals > 3 > cash Flow > depreciation
24752000
Annuals > 3 > cash Flow > change In Working Capital
-176631000
Annuals > 3 > cash Flow > cash From Operations
368570000
Annuals > 3 > cash Flow > capital Expenditures
14850000
Annuals > 3 > cash Flow > cash From Investing
105655000
Annuals > 3 > cash Flow > cash From Financing
-159049000
Annuals > 3 > cash Flow > net Change In Cash
315088000
Annuals > 3 > ratios > PE
1.4925286248980245
Annuals > 3 > ratios > PB
1.3066392920421301
Annuals > 3 > ratios > ROE
57.69812265649019
Annuals > 3 > ratios > ROA
9.48961463313934
Annuals > 3 > ratios > FCF
353720000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.4425704419198238
Annuals > 3 > health Score
76
Valuation > metrics > PE
-0.1766344352826524
Valuation > metrics > PB
2.1221171514363824
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-10.412193462433233
Profitability > metrics > ROA
-7.842463336269091
Profitability > metrics > Net Margin
-0.6138842181119385
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.7003214595649498
Risk > metrics > Interest Coverage
16.867329047340736
Risk > final Score
70
Risk > verdict
Low
Liquidity > metrics > Current Ratio
24.249665128739395
Liquidity > metrics > Quick Ratio
20.876692960261945
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-9
Prev Risks > 1
1
Prev Risks > 2
16
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T17:46:05.383Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.066
Earnings History > 0 > eps Difference
0.066
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.08
Earnings History > 1 > eps Estimate
-0.0784
Earnings History > 1 > eps Difference
-0.0016
Earnings History > 1 > surprise Percent
-2.0408
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-11
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.08
Earnings History > 2 > eps Estimate
-0.07
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-14.2857
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-23
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.02
Earnings History > 3 > eps Estimate
-0.02
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
0
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-20
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.06
Earnings History > 4 > eps Estimate
-0.0401
Earnings History > 4 > eps Difference
-0.0199
Earnings History > 4 > surprise Percent
-49.6259
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.02
Earnings History > 5 > eps Estimate
-0.01
Earnings History > 5 > eps Difference
-0.01
Earnings History > 5 > surprise Percent
-100
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-07
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0558
Earnings History > 6 > eps Estimate
-0.0008
Earnings History > 6 > eps Difference
-0.055
Earnings History > 6 > surprise Percent
-6875
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.02
Earnings History > 7 > eps Estimate
-0.03
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
33.3333
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-22
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.01
Earnings History > 8 > eps Estimate
-0.01
Earnings History > 8 > eps Difference
0.02
Earnings History > 8 > surprise Percent
200
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.01
Earnings History > 9 > eps Estimate
0.01
Earnings History > 9 > eps Difference
-0.02
Earnings History > 9 > surprise Percent
-200
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-07
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.05
Earnings History > 10 > eps Estimate
0.01
Earnings History > 10 > eps Difference
-0.06
Earnings History > 10 > surprise Percent
-600
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-08
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.03
Earnings History > 11 > eps Estimate
0.04
Earnings History > 11 > eps Difference
-0.01
Earnings History > 11 > surprise Percent
-25
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-22
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.35
Earnings History > 12 > eps Estimate
0.34
Earnings History > 12 > eps Difference
0.01
Earnings History > 12 > surprise Percent
2.9412
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-02
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.37
Earnings History > 13 > eps Estimate
0.33
Earnings History > 13 > eps Difference
0.04
Earnings History > 13 > surprise Percent
12.1212
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-04
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.54
Earnings History > 14 > eps Estimate
0.45
Earnings History > 14 > eps Difference
0.09
Earnings History > 14 > surprise Percent
20
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-05
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.54
Earnings History > 15 > eps Estimate
0.44
Earnings History > 15 > eps Difference
0.1
Earnings History > 15 > surprise Percent
22.7273
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-23
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.45
Earnings History > 16 > eps Estimate
0.38
Earnings History > 16 > eps Difference
0.07
Earnings History > 16 > surprise Percent
18.4211
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.44
Earnings History > 17 > eps Estimate
0.35
Earnings History > 17 > eps Difference
0.09
Earnings History > 17 > surprise Percent
25.7143
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-10
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0.44
Earnings History > 18 > eps Estimate
0.32
Earnings History > 18 > eps Difference
0.12
Earnings History > 18 > surprise Percent
37.5
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-10
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.26
Earnings History > 19 > eps Estimate
0.21
Earnings History > 19 > eps Difference
0.05
Earnings History > 19 > surprise Percent
23.8095
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-02
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.13
Earnings History > 20 > eps Estimate
0.11
Earnings History > 20 > eps Difference
0.02
Earnings History > 20 > surprise Percent
18.1818
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-23
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.02
Earnings History > 21 > eps Estimate
0.17
Earnings History > 21 > eps Difference
-0.19
Earnings History > 21 > surprise Percent
-111.7647
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMaravai LifeSciences Holdings, Inc. $MRVI Stock Holdings Boosted by Immersion Corp - MarketBeat
12/12/2025
Maravai LifeSciences Holdings, Inc. $MRVI Stock Holdings Boosted by Immersion Corp MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$3.8571
Analyst Picks
Strong Buy
5
Buy
1
Hold
7
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 91.59% of the total shares of Maravai Lifesciences Holdings Inc
1.
GTCR LLC(13.9275%)
since
2025/06/30
2.
12 West Capital Management LP(8.6546%)
since
2025/06/30
3.
BlackRock Inc(6.7005%)
since
2025/06/30
4.
Vanguard Group Inc(6.4838%)
since
2025/06/30
5.
BRAIDWELL LP(5.7737%)
since
2025/06/30
6.
Mackenzie Investments(4.195%)
since
2025/06/30
7.
Canada Life US Small-Mid Cap Growth F(3.1611%)
since
2025/06/30
8.
Renaissance Technologies Corp(2.8935%)
since
2025/06/30
9.
Vanguard Total Stock Mkt Idx Inv(2.7196%)
since
2025/07/31
10.
Mirabella Financial Services LLP(2.592%)
since
2025/06/30
11.
Point72 (DIFC) Ltd(2.5709%)
since
2025/06/30
12.
UBS Group AG(2.2341%)
since
2025/06/30
13.
iShares Russell 2000 ETF(2.075%)
since
2025/08/31
14.
Geode Capital Management, LLC(2.0625%)
since
2025/06/30
15.
Morgan Stanley - Brokerage Accounts(1.9886%)
since
2025/06/30
16.
T. Rowe Price Investment Management,Inc.(1.8273%)
since
2025/06/30
17.
Philosophy Capital Management LLC(1.7924%)
since
2025/06/30
18.
State Street Corp(1.6459%)
since
2025/06/30
19.
Two Sigma Advisers, LLC(1.5376%)
since
2025/06/30
20.
T. Rowe Price Small-Cap Stock(1.3515%)
since
2025/07/31
21.
Tejara Capital Ltd(1.3419%)
since
2025/06/30
22.
Deutsche Bank AG(1.2955%)
since
2025/06/30
23.
Systematic Financial Management LP(1.1555%)
since
2025/06/30
24.
CenterBook Partners LP(1.1298%)
since
2025/06/30
25.
Vanguard Small Cap Index(0.9658%)
since
2025/07/31
26.
Vanguard Institutional Extnd Mkt Idx Tr(0.9032%)
since
2025/07/31
27.
Fidelity Small Cap Index(0.8475%)
since
2025/06/30
28.
Columbia Small Cap Value Discv A(0.7933%)
since
2025/07/31
29.
Columbia Small Cap Value Discovery Fund(0.7715%)
since
2025/06/30
30.
T. Rowe Price Small-Cap Value(0.7601%)
since
2025/07/31
31.
Xtrackers MSCI World Swap ETF 1C(0.7488%)
since
2025/07/31
32.
iShares Russell 2000 Value ETF(0.7317%)
since
2025/08/31
33.
T. Rowe Price Instl Small-Cap Stock(0.6826%)
since
2025/07/31
34.
Vanguard Small Cap Growth Index Inv(0.5423%)
since
2025/07/31
35.
Xtrackers S&P 500 Swap ETF 1C(0.5115%)
since
2025/07/31
36.
Royce Micro Cap Trust(0.4872%)
since
2025/06/30
37.
Fidelity Extended Market Index(0.4568%)
since
2025/07/31
38.
iShares Biotechnology ETF(0.437%)
since
2025/08/31
39.
Pender Global Small/Mid Cap Eq F(0.4247%)
since
2025/05/31
40.
IG Mackenzie U.S. Small-Mid Cap Growth C(0.4195%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.066
Date
2025-09-30
EPS Actual
-0.08
EPS Estimate
-0.0784
EPS Difference
-0.0016
Surprise Percent
-2.0408%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.